Background illustration for clinical trials search

Paid Clinical Trials Hayward

Discover 2,218 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

for
Mesial Temporal Lobe Epilepsy
Location: Palo Alto CA, San Francisco CA, Sacramento CA,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05135091

Phase 3, Recruiting
Active & Responsive

GBPDC: Gut-Brain in PD Consortium Master Protocol

for
Parkinson Disease (PD), PARKINSON DISEASE (Disorder),
Location: Stanford CA, Rochester MN, Chicago IL, Boston MA
Sponsor: Duke University

Sex: All

Age: 21 - 70+

Code: NCT07567794

Recruiting
Active & Responsive

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Palo Alto CA, San Francisco CA, Duarte CA, Portland OR,
Sponsor: Kelonia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07075185

Phase 1, Recruiting
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Palo Alto CA, Los Angeles CA, Orange CA, La Jolla CA,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase 2, Recruiting
Active & Responsive

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

for
Hemophilia A
Location: Palo Alto CA, San Diego CA, Oklahoma City OK,
Sponsor: Wayne State University

Sex: All

Age: 6 - 19

Code: NCT05022459

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Voices Illuminating Solutions for Outdoor Workers' Needs and Safety

for
Air Pollution Exposure
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT07713264

Recruiting
Active & Responsive

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

for
Colorectal Cancer
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT07403981

Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Palo Alto CA, San Francisco CA, Los Angeles CA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase 3, Recruiting
Active & Responsive

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

for
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\),
Location: Stanford CA, Los Angeles CA, Dallas TX, Saint Paul MN,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 5

Code: NCT06503367

Recruiting
Active & Responsive

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

for
Lymphoblastic Leukemia
Location: Palo Alto CA, Madera CA, Los Angeles CA, Orange CA,
Sponsor: Tanja Andrea Gruber

Sex: All

Age: 0 - 1

Code: NCT05848687

Phase 1, Phase 2, Recruiting
Active & Responsive

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

for
Autism Spectrum Disorder (ASD), Autism
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 6 - 12

Code: NCT06627205

Recruiting
Active & Responsive

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

for
Immunization; Infection, Transplantation Infection, Influenza
Location: Stanford CA, Seattle WA, Kansas City MO, Houston TX,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 17

Code: NCT05947071

Phase 2, Recruiting
Active & Responsive

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

for
Refractory Acute Myeloid Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06561152

Phase 1, Phase 2, Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Stanford CA, Los Angeles CA, Portland OR,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

for
Acute Myeloid Leukemia
Location: Stanford CA, Duarte CA, Salt Lake City UT, Phoenix AZ,
Sponsor: Norman J. Lacayo

Sex: All

Age: 0 - 21

Code: NCT05101551

Phase 1, Recruiting
Active & Responsive

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

for
Alpha1-Antitrypsin Deficiency
Location: Palo Alto CA, San Francisco CA, Los Angeles CA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT05677971

Phase 3, Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Palo Alto CA, San Francisco CA, Los Angeles CA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase 2, Recruiting
Active & Responsive

Study of Cryoablation and Nirogacestat for Desmoid Tumor

for
Desmoid Tumor
Location: Palo Alto CA
Sponsor: Nam Bui

Sex: All

Age: 18+

Code: NCT05949099

Phase 2, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Newport Beach CA, Redwood City CA, San Francisco CA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Newport Beach CA, Redwood City CA, San Francisco CA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting